Literature DB >> 21475233

A new treasure in the breast cancer gene hunt.

Paul Spellman, Joe Gray.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21475233     DOI： 10.1038/nm0411-422

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  9 in total

1.  Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer.

Authors:  Anna Bergamaschi; Young H Kim; Pei Wang; Therese Sørlie; Tina Hernandez-Boussard; Per E Lonning; Robert Tibshirani; Anne-Lise Børresen-Dale; Jonathan R Pollack
Journal:  Genes Chromosomes Cancer       Date:  2006-11       Impact factor: 5.006

2.  Zeppo1 is a novel metastasis promoter that represses E-cadherin expression and regulates p120-catenin isoform expression and localization.

Authors:  Euan M Slorach; Jonathan Chou; Zena Werb
Journal:  Genes Dev       Date:  2011-02-11       Impact factor: 11.361

3.  Comprehensive profiling of 8p11-12 amplification in breast cancer.

Authors:  Véronique Gelsi-Boyer; Béatrice Orsetti; Nathalie Cervera; Pascal Finetti; Fabrice Sircoulomb; Carole Rougé; Laurence Lasorsa; Anne Letessier; Christophe Ginestier; Florence Monville; Séverine Esteyriès; José Adélaïde; Benjamin Esterni; Catherine Henry; Stephen P Ethier; Frédéric Bibeau; Marie-Joëlle Mozziconacci; Emmanuelle Charafe-Jauffret; Jocelyne Jacquemier; François Bertucci; Daniel Birnbaum; Charles Theillet; Max Chaffanet
Journal:  Mol Cancer Res       Date:  2005-12       Impact factor: 5.852

4.  Genomic and transcriptional aberrations linked to breast cancer pathophysiologies.

Authors:  Koei Chin; Sandy DeVries; Jane Fridlyand; Paul T Spellman; Ritu Roydasgupta; Wen-Lin Kuo; Anna Lapuk; Richard M Neve; Zuwei Qian; Tom Ryder; Fanqing Chen; Heidi Feiler; Taku Tokuyasu; Chris Kingsley; Shanaz Dairkee; Zhenhang Meng; Karen Chew; Daniel Pinkel; Ajay Jain; Britt Marie Ljung; Laura Esserman; Donna G Albertson; Frederic M Waldman; Joe W Gray
Journal:  Cancer Cell       Date:  2006-12       Impact factor: 31.743

5.  Activation of an estrogen/estrogen receptor signaling by BIG3 through its inhibitory effect on nuclear transport of PHB2/REA in breast cancer.

Authors:  Jung-Won Kim; Miki Akiyama; Jae-Hyun Park; Meng-Lay Lin; Arata Shimo; Tomomi Ueki; Yataro Daigo; Tatsuhiko Tsunoda; Toshihiko Nishidate; Yusuke Nakamura; Toyomasa Katagiri
Journal:  Cancer Sci       Date:  2009-05-06       Impact factor: 6.716

6.  Characterization of the recurrent 8p11-12 amplicon identifies PPAPDC1B, a phosphatase protein, as a new therapeutic target in breast cancer.

Authors:  Isabelle Bernard-Pierrot; Nadège Gruel; Nicolas Stransky; Anne Vincent-Salomon; Fabien Reyal; Virginie Raynal; Céline Vallot; Gaëlle Pierron; François Radvanyi; Olivier Delattre
Journal:  Cancer Res       Date:  2008-09-01       Impact factor: 12.701

7.  ZNF703 gene amplification at 8p12 specifies luminal B breast cancer.

Authors:  Fabrice Sircoulomb; Nathalie Nicolas; Anthony Ferrari; Pascal Finetti; Ismahane Bekhouche; Estelle Rousselet; Aurélie Lonigro; José Adélaïde; Emilie Baudelet; Séverine Esteyriès; Julien Wicinski; Stéphane Audebert; Emmanuelle Charafe-Jauffret; Jocelyne Jacquemier; Marc Lopez; Jean-Paul Borg; Christos Sotiriou; Cornel Popovici; François Bertucci; Daniel Birnbaum; Max Chaffanet; Christophe Ginestier
Journal:  EMBO Mol Med       Date:  2011-02-15       Impact factor: 12.137

8.  ZNF703 is a common Luminal B breast cancer oncogene that differentially regulates luminal and basal progenitors in human mammary epithelium.

Authors:  Daniel G Holland; Angela Burleigh; Anna Git; Mae A Goldgraben; Pedro A Perez-Mancera; Suet-Feung Chin; Antonio Hurtado; Alejandra Bruna; H Raza Ali; Wendy Greenwood; Mark J Dunning; Shamith Samarajiwa; Suraj Menon; Oscar M Rueda; Andy G Lynch; Steven McKinney; Ian O Ellis; Connie J Eaves; Jason S Carroll; Christina Curtis; Samuel Aparicio; Carlos Caldas
Journal:  EMBO Mol Med       Date:  2011-02-18       Impact factor: 12.137

9.  FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer.

Authors:  Nicholas Turner; Alex Pearson; Rachel Sharpe; Maryou Lambros; Felipe Geyer; Maria A Lopez-Garcia; Rachael Natrajan; Caterina Marchio; Elizabeth Iorns; Alan Mackay; Cheryl Gillett; Anita Grigoriadis; Andrew Tutt; Jorge S Reis-Filho; Alan Ashworth
Journal:  Cancer Res       Date:  2010-02-23       Impact factor: 12.701
  9 in total
  9 in total

1.  Lymphovascular invasion and histologic grade are associated with specific genomic profiles in invasive carcinomas of the breast.

Authors:  Felipe Fidalgo; Tatiane Cristina Rodrigues; Mabel Pinilla; Amanda Gonçalves Silva; Maria do Socorro Maciel; Carla Rosenberg; Victor Piana de Andrade; Dirce Maria Carraro; Ana Cristina Victorino Krepischi
Journal:  Tumour Biol       Date:  2014-11-13

2.  Cyclin alterations in diverse cancers: Outcome and co-amplification network.

Authors:  Maria Schwaederlé; Gregory A Daniels; David E Piccioni; Paul T Fanta; Richard B Schwab; Kelly A Shimabukuro; Barbara A Parker; Razelle Kurzrock
Journal:  Oncotarget       Date:  2015-02-20

3.  Elevated ZNF703 Protein Expression Is an Independent Unfavorable Prognostic Factor for Survival of the Patients with Head and Neck Squamous Cell Carcinoma.

Authors:  Hang Yang; Wen-Qi Jiang; Ye Cao; Yong-An Sun; Jing Wei; Xin An; Ying-Chun Zhang; Ming Song; Shu-Sen Wang; Zhong-Yu Yuan; Rou-Jun Peng; Tan-Huan Chen; Li-Ren Li; Yan-Xia Shi
Journal:  Dis Markers       Date:  2015-04-29       Impact factor: 3.434

4.  Luminal breast cancer cell lines overexpressing ZNF703 are resistant to tamoxifen through activation of Akt/mTOR signaling.

Authors:  Xi Zhang; Xin Mu; Ou Huang; Zuoquan Xie; Min Jiang; Meiyu Geng; Kunwei Shen
Journal:  PLoS One       Date:  2013-08-26       Impact factor: 3.240

5.  Amplification of chromosome 8 genes in lung cancer.

Authors:  Onur Baykara; Burak Bakir; Nur Buyru; Kamil Kaynak; Nejat Dalay
Journal:  J Cancer       Date:  2015-01-20       Impact factor: 4.207

6.  Overexpression of ZNF703 facilitates tumorigenesis and predicts unfavorable prognosis in patients with cholangiocarcinoma.

Authors:  Keyu Li; Jiabei Wang; Jihua Han; Yaliang Lan; Changming Xie; Shangha Pan; Lianxin Liu
Journal:  Oncotarget       Date:  2016-11-15

7.  Copy number changes at 8p11-12 predict adverse clinical outcome and chemo- and radiotherapy response in breast cancer.

Authors:  Cathy B Moelans; Caroline M G van Maldegem; Elsken van der Wall; Paul J van Diest
Journal:  Oncotarget       Date:  2018-03-30

8.  ZNF703 promotes triple-negative breast cancer cells through cell-cycle signaling and associated with poor prognosis.

Authors:  Xi Zhang; Xin Mu; Ou Huang; Zhitang Wang; Jialin Chen; Debo Chen; Gen Wang
Journal:  BMC Cancer       Date:  2022-03-02       Impact factor: 4.430

9.  ZNF703 Overexpression may act as an oncogene in non-small cell lung cancer.

Authors:  Onur Baykara; Nejat Dalay; Kamil Kaynak; Nur Buyru
Journal:  Cancer Med       Date:  2016-09-20       Impact factor: 4.452
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.